Evidence map›Paper›PMID 41577247›Full record

ReviewKidney international2026

Eligibility, timing, and organ quality: indications and outcomes of kidney transplantation in older patients.

Constantin Kupsch, Sarah Tsou, Friederike Martin, Rosalie Wolff von Gudenberg, Stefan Fichtner-Feigl, Reza Abdi, Stefan G Tullius

Abstract readReview
In one paragraph

Review in Kidney international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Constantin KupschDivision of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of General and Visceral Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
Sarah TsouDivision of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Friederike MartinDivision of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Surgery, Charité-Universitätsmedizin Berlin, Campus Charité Mitte | Campus Virchow-Klinikum, Berlin, Germany.
Rosalie Wolff von GudenbergDivision of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Stefan Fichtner-FeiglDepartment of General and Visceral Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
Reza AbdiRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Stefan G TulliusDivision of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: stullius@bwh.harvard.edu.

Funding

The KAPP-Sen Tissue Mapping Center CollaborativeU54AG075941 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GAROVIC, VESNA D, KUCHEL, GEORGE A · 2021 to 2025
$13.8M
Nano Immune-Imaging CoreP01AI175397 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Reza Abdi, Stefan Gunther Tullius · 2024 to 2026
$9.5M
Senescent cells drive mt-DNA accumulation and inflamm-agingR01AG064165 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI TULLIUS, STEFAN GUNTHER · 2020 to 2024
$2.6M
Understanding Interorgan Communication Through Heterochronic Organ TransplantationU01AG086168 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Vadim N. Gladyshev, Stefan Gunther Tullius · 2024 to 2026
$2.0M
NIAID NIH HHS P01 AI175397NIA NIH HHS R01 AG064165NIA NIH HHS U01 AG086168NIA NIH HHS U54 AG075941
6 · The paper itself

Abstract

Kidney transplantation remains the gold standard treatment for end-stage renal disease. The rising prevalence of this condition, at the same time, contributes significantly to the increasing discrepancy between organ supply and demand, impacting the opportunities for treatment while creating challenges for providers and health care systems worldwide. Driven by demographic shifts, the most significant growth in transplant candidates is observed in the older population. Here, we detail characteristics of older recipients who may benefit most from transplantation, with an emphasis on data-driven assessment for candidate selection while also considering the impact of donor organ quality, donation type, and waiting times. Distinguishing between patients with end-stage renal disease who will benefit from transplantation and those who will derive less or no benefit is essential for providing optimal care to older patients while ensuring responsible stewardship of the limited organ supply. We highlight the advantages of preemptive or expedited transplantation to minimize dialysis exposure and address specific considerations for the peri- and postoperative period. Although living donation remains ideal and will shorten the waiting time, kidneys from older or high kidney donor profile index donors show satisfactory outcomes, particularly for older recipients.

Indexed as

Donor SelectionEligibility DeterminationKidney Failure, ChronicKidney TransplantationPatient SelectionAgedAge FactorsHumansLiving DonorsTime FactorsTreatment OutcomeWaiting ListsagingcomorbidityfrailtyKDPItransplantationwaitlist

Identifiers

PMID41577247
PMCPMC13551626

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.